Brain Biotechnology Research And Information Network AG logo

BNN - Brain Biotechnology Research And Information Network AG Share Price

€7.4 0.1  1.7%

Last Trade - 8:40am

Sector
Basic Materials
Size
Small Cap
Market Cap £136.8m
Enterprise Value £136.8m
Revenue £37.4m
Position in Universe 632nd / 1041
Bullish
Bearish
Unlock BNN Revenue
Momentum
Relative Strength (%)
1m -14.2%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -49.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
13.0 23.9 25.0 26.4 29.1 40.0 40.4 46.2 +25.3%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Brain Biotechnology RCH & Info Netwk AG revenues increased 3% to EUR20.3M. Net loss applicable to common stockholders decreased 24% to EUR4M. Revenues reflect Revenue increase of 6% to EUR19.9M. Lower net loss reflects Depreciation and amortization and impair decrease of 46% to EUR1.7M (expense), Other expenses decrease of 22% to EUR3.3M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BNN Revenue Unlock BNN Revenue

Net Income

BNN Net Income Unlock BNN Revenue

Normalised EPS

BNN Normalised EPS Unlock BNN Revenue

PE Ratio Range

BNN PE Ratio Range Unlock BNN Revenue

Dividend Yield Range

BNN Dividend Yield Range Unlock BNN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BNN EPS Forecasts Unlock BNN Revenue
Profile Summary

BRAIN Biotechnology Research and Information Network AG is a Germany-based industrial biotechnology company, which is active in two segments: The BioSciences segment comprises research and development activities related to replacing classical chemical and industrial processes with biotechnology processes, and the BioIndustrial segment focuses on the development of own products for both companies and consumers. The Company develops drugs, bioactive natural compounds and enzymes for customers in the chemical and pharmaceutical industries, as well as in the food and cosmetics industries. It offers research and development collaboration, as well as strategic partnerships and exclusive licensing agreements through all phases of enzyme and biological compound discovery to application development and production. The Company's product portfolio includes EvoSolution, METAGENOME, BRAINzyme, LIL, ABEL, CompActives and BioCompActives.

Directors
Last Annual September 30th, 2019
Last Interim June 30th, 2020
Public Since February 9, 2016
No. of Shareholders: n/a
No. of Employees: 275
Sector Basic Materials
Industry Chemicals
Index
Exchange Frankfurt Stock Exchange
Shares in Issue 19,861,360
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BNN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BNN
Upcoming Events for BNN
Frequently Asked Questions for Brain Biotechnology Research and Information Network AG
What is the Brain Biotechnology Research and Information Network AG share price?

As of 8:40am, shares in Brain Biotechnology Research and Information Network AG are trading at €7.4, giving the company a market capitalisation of £136.8m. This share price information is delayed by 15 minutes.

How has the Brain Biotechnology Research and Information Network AG share price performed this year?

Shares in Brain Biotechnology Research and Information Network AG are currently trading at €7.4 and the price has moved by -30.67% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Brain Biotechnology Research and Information Network AG price has moved by -25.62% over the past year.

What are the analyst and broker recommendations for Brain Biotechnology Research and Information Network AG?

Of the analysts with advisory recommendations for Brain Biotechnology Research and Information Network AG, there are there are currently 1 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Brain Biotechnology Research and Information Network AG is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Brain Biotechnology Research and Information Network AG next release its financial results?

Brain Biotechnology Research and Information Network AG is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Brain Biotechnology Research and Information Network AG dividend yield?

Brain Biotechnology Research and Information Network AG does not currently pay a dividend.

Does Brain Biotechnology Research and Information Network AG pay a dividend?

Brain Biotechnology Research and Information Network AG does not currently pay a dividend.

When does Brain Biotechnology Research and Information Network AG next pay dividends?

Brain Biotechnology Research and Information Network AG does not currently pay a dividend.

How do I buy Brain Biotechnology Research and Information Network AG shares?

To buy shares in Brain Biotechnology Research and Information Network AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Brain Biotechnology Research and Information Network AG?

Shares in Brain Biotechnology Research and Information Network AG are currently trading at €7.4, giving the company a market capitalisation of £136.8m.

Where are Brain Biotechnology Research and Information Network AG shares listed? Where are Brain Biotechnology Research and Information Network AG shares listed?

Here are the trading details for Brain Biotechnology Research and Information Network AG:

Country of listing: Germany
Exchange: FRA
Ticker Symbol: BNN
What kind of share is Brain Biotechnology Research and Information Network AG?

Based on an overall assessment of its quality, value and momentum, Brain Biotechnology Research and Information Network AG is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Brain Biotechnology Research and Information Network AG share price forecast 2020?

Shares in Brain Biotechnology Research and Information Network AG are currently priced at €7.4. At that level they are trading at 0.111% discount to the analyst consensus target price of 0.00.

Analysts covering Brain Biotechnology Research and Information Network AG currently have a consensus Earnings Per Share (EPS) forecast of -0.372 for the next financial year.

How can I tell whether the Brain Biotechnology Research and Information Network AG share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Brain Biotechnology Research and Information Network AG. Over the past six months, the relative strength of its shares against the market has been -1.19%. At the current price of €7.4, shares in Brain Biotechnology Research and Information Network AG are trading at -16.33% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Brain Biotechnology Research and Information Network AG PE Ratio?

We were not able to find PE ratio data for Brain Biotechnology Research and Information Network AG.

Who are the key directors of Brain Biotechnology Research and Information Network AG?

Brain Biotechnology Research and Information Network AG's management team is headed by:

Georg Kellinghusen - CSU
Ute Dechert - OTH
Michael Krohn - EVP
Martin Langer - EVP
Guido Meurer - EVP
Anna Eichhorn - VSU
Manfred Bender - CFO
Lukas Linnig - OTH
Alexander Pelzer - OTH
Adriaan Moelker - CMG
Bernhard Hauer - SUB
Michael Majerus - SUB
Who are the major shareholders of Brain Biotechnology Research and Information Network AG?

Here are the top five shareholders of Brain Biotechnology Research and Information Network AG based on the size of their shareholding:

Putsch (Martin) Individual Investor
Percentage owned: 34.45% (6.84m shares)
Founders and management of BRAIN Biotechnology Research and Corporation
Percentage owned: 8% (1.59m shares)
Hopp (Daniel) Individual Investor
Percentage owned: 7.82% (1.55m shares)
Universal-Investment-Gesellschaft mbH Investment Advisor/Hedge Fund
Percentage owned: 6.81% (1.35m shares)
Lloyd Fonds - WHC Global Discovery Mutual Fund
Percentage owned: 3.9% (774k shares)
Similar to BNN
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.